Ann: Phase I Clinical Trial of R327 I.V. - 6000mg Complete, page-15

maybe a misunderstanding. I was reffering to current trial as sepsis phase 1 even though i am aware that phase 1 is purely safety and in this case not efficacy against sepsis.

Any results published on what i am calling sepsis phase 1 will really only tell us this can be infused by iv saftely in healthy subjects.

The phase 2 where we actually administer to sepsis patients will be a whole different ball game although I would assume their previous animal trials would convince them there should be no issues. Im just curious how we get approval to access and treat patients for phase 2. Surely would have to be administered in an emergency environment rather than clinical trial lab?